Avalo Therapeutics, Inc. · NASDAQ:AVTX

Avoro Capital Advisors LLC reported a 5.75% stake in Avalo Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Avoro Capital Advisors LLC reported a 5.75% stake in Avalo Therapeutics, Inc., 1,410,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
5.75%
Shares
1,410,000
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Avoro Capital Advisors LLC5.75%1,410,000
Behzad Aghazadeh5.75%1,410,000

Source

View original at SEC

Related